Dashboard
Manage Tickers

NVCRNovoCure Ltd

Nasdaq novocure.com


$ 19.22 $ -0.25 (-1.28 %)    

Wednesday, 07-Aug-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.72 $ -4.76 (-1.08 %)
DIA $ 387.79 $ -2.19 (-0.56 %)
SPY $ 518.50 $ -3.49 (-0.67 %)
TLT $ 95.87 $ -0.68 (-0.7 %)
GLD $ 220.55 $ -0.15 (-0.07 %)
$ 19.21
$ 19.19 x 100
-- x --
-- - --
$ 10.87 - $ 31.81
1,188,410
na
2.07B
$ 1.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-25-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 10-26-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 10-27-2022 09-30-2022 10-Q
9 07-28-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 04-30-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 07-25-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 10-25-2018 09-30-2018 10-Q
25 07-26-2018 06-30-2018 10-Q
26 04-26-2018 03-31-2018 10-Q
27 02-22-2018 12-31-2017 10-K
28 10-26-2017 09-30-2017 10-Q
29 07-27-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 11-02-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-01-2016 12-31-2015 10-K
36 10-27-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

paypal-posts-upbeat-earnings-joins-sprouts-farmers-market-stanley-black--decker-phillips-66-and-other-big-stocks-moving-higher-on-tuesday
PayPal Posts Upbeat Earnings, Joins Sprout...
07/30/2024 14:46:55

wells-fargo-maintains-overweight-on-novocure-lowers-price-target-to-40
Wells Fargo Maintains Overweight on NovoCu...
07/26/2024 12:47:16

Wells Fargo analyst Larry Biegelsen maintains NovoCure (NASDAQ:NVCR) with a Overweight and lowers the price target from $42 ...

beyond-the-numbers-4-analysts-discuss-novocure-stock
Beyond The Numbers: 4 Analysts Discuss Nov...
07/26/2024 12:01:53

hc-wainwright--co-maintains-neutral-on-novocure-raises-price-target-to-24
HC Wainwright & Co. Maintains Neutral on N...
07/26/2024 09:54:32

HC Wainwright & Co. analyst Emily Bodnar maintains NovoCure (NASDAQ:NVCR) with a Neutral and raises the price target fro...

novocure-q2-2024-gaap-eps-031-beats-041-estimate-sales-150356m-beat-135823m-estimate
NovoCure Q2 2024 GAAP EPS $(0.31) Beats $(...
07/25/2024 11:03:12

breaking-down-novocure-4-analysts-share-their-views
Breaking Down NovoCure: 4 Analysts Share T...
07/02/2024 19:01:59

evercore-isi-group-maintains-in-line-on-novocure-raises-price-target-to-20
Evercore ISI Group Maintains In-Line on No...
07/02/2024 15:51:08

Evercore ISI Group analyst Vijay Kumar maintains NovoCure (NASDAQ:NVCR) with a In-Line and raises the price target from $14....

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
06/07/2024 17:35:20

a-closer-look-at-7-analyst-recommendations-for-novocure
A Closer Look at 7 Analyst Recommendations...
06/04/2024 13:01:00

hc-wainwright--co-reiterates-neutral-on-novocure-maintains-22-price-target
HC Wainwright & Co. Reiterates Neutral on ...
06/04/2024 10:10:50

HC Wainwright & Co. analyst Emily Bodnar reiterates NovoCure (NASDAQ:NVCR) with a Neutral and maintains $22 price target.

novocure-reports-presentation-of-clinical-data-from-phase-3-metis-trial-says-trial-met-its-primary-endpoint-demonstrating-statistically-significant-improvement-in-time-to-intracranial-progression
Novocure Reports Presentation Of Clinical ...
06/03/2024 12:02:58

Patients treated with TTFields therapy and BSC exhibited a median time to intracranial progression of 21.9 months compared to 1...

overseas-shipholding-micron-squarespace-incyte-and-other-big-stocks-moving-higher-on-monday
Overseas Shipholding, Micron, Squarespace,...
05/20/2024 15:37:53

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/15/2024 17:35:22

unveiling-8-analyst-insights-on-novocure
Unveiling 8 Analyst Insights On NovoCure
05/02/2024 21:01:09

hc-wainwright--co-maintains-neutral-on-novocure-lowers-price-target-to-22
HC Wainwright & Co. Maintains Neutral on N...
05/02/2024 16:41:26

HC Wainwright & Co. analyst Emily Bodnar maintains NovoCure (NASDAQ:NVCR) with a Neutral and lowers the price target fro...

novocure-secures-400m-multi-tranche-non-dilutive-debt-financing-from-pharmakon
Novocure Secures $400M Multi-Tranche Non-D...
05/02/2024 11:37:19

novocure-secures-new-400m-non-dilutive-debt-financing-from-pharmakon
Novocure Secures New $400M Non-Dilutive De...
05/02/2024 11:18:50

Use of proceeds to fund working capital needs stemming from Novocure's anticipated launch in non-small cell lung cancer and...

novocure-q1-2024-adj-eps-036-beats-042-estimate-sales-13850m-beat-13145m-estimate
NovoCure Q1 2024 Adj EPS $(0.36) Beats $(0...
05/02/2024 11:04:47

NovoCure (NASDAQ:NVCR) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.42) by 1...

results-of-novocures-metis-phase-3-clinical-trial-for-patients-with-brain-metastasis-from-non-small-cell-lung-cancer-to-be-presented-as-late-breaking-abstract-at-asco-2024
Results Of Novocure's METIS Phase 3 Clinic...
04/24/2024 14:46:57

Novocure (NASDAQ:NVCR) today announced the results of the METIS phase 3 clinical trial in brain metastases from non-small cell ...

piper-sandler-reiterates-overweight-on-novocure-raises-price-target-to-28
Piper Sandler Reiterates Overweight on Nov...
04/10/2024 12:55:11

Piper Sandler analyst Jason Bednar reiterates NovoCure (NASDAQ:NVCR) with a Overweight and raises the price target from $25 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION